cardiac allograft vasculopathy , CAV (Abkürzung)
coronary vasculopathy

Anti-HLA antibodies are associated with restenosis after percutaneous coronary intervention for cardiac allograft vasculopathy.

His practice has a primary focus on the understanding and treatment of cardiac allograft vasculopathy, a condition affecting about half of all transplant recipients by their fifth year.

This test is not designed to be informative about other forms of heart rejections such as antibody-mediated rejection (AMR) or cardiac allograft vasculopathy (CAV).